Image

Innovative Approaches to Enhance Balance and Neuroplasticity in Multiple Sclerosis

Innovative Approaches to Enhance Balance and Neuroplasticity in Multiple Sclerosis

Recruiting
18-65 years
All
Phase N/A

Powered by AI

Overview

This study will evaluate the effects of combining balance training with electrical stimulation techniques in individuals with Multiple Sclerosis (MS). MS commonly impairs leg strength, coordination, and balance, increasing the risk of falls and reducing independence. The interventions include:Balance training only, Balance training with Functional Electrical Stimulation (FES), and Balance training with FES and Transcutaneous Spinal Cord Stimulation (TSCS). FES delivers small electrical pulses to leg muscles, while TSCS delivers electrical signals through the skin to stimulate the spinal cord and enhance motor control.

The study will enroll up to 24 participants over a 3-year period. This trial is funded by MS Canada. Participants will be randomly assigned to one of three groups: (1) balance training only, (2) balance training with FES, or (3) balance training with FES and TSCS. All participants will complete 12 supervised training sessions over 6 weeks. During each session, participants will engage in interactive balance games while standing in a safety harness.Outcome assessments will be conducted at three time points: baseline (prior to training), post-intervention (after 6 weeks), and follow-up (8 weeks after training).

Assessments will include:

  • Clinical tests of mobility and balance (Timed Up and Go:TUG, 10-Meter Walk Test:10MWT, Berg Balance Scale:BBS)
  • Computerized balance testing using a force plate
  • Questionnaires on walking ability, fear of falling, and balance confidence
  • Neurophysiological measures of brain-spinal cord-muscle communication before and after training

Eligibility

Participants will be eligible if they meet the following conditions:

  • Confirmed diagnosis of Multiple Sclerosis (MS) according to the revised McDonald criteria
  • Age ≤ 65 years
  • Ability to walk at least 100 meters, with or without an assistive device, and without requiring rest
  • Self-reported perception of impaired balance during standing or walking in daily activities

Exclusion Criteria:

  • Participants will be excluded if they present with any of the following:
  • Uncorrected visual problems
  • Cognitive impairment affecting comprehension of instructions or completion of self-administered outcome measures
  • Ongoing MS exacerbation or paroxysmal vertigo
  • Concurrent neurological or orthopedic conditions affecting balance
  • Recent participation in rehabilitation therapies (physical therapy, occupational therapy, or vestibular therapy) within one month prior to recruitment
  • Planned or recent injection of botulinum toxin to the legs during the intervention period
  • Peripheral nerve damage affecting the legs
  • Contraindications to electrical stimulation, including:implanted electronic device, active cancer or radiation treatment within the past 6 months, uncontrolled epilepsy, skin rash or open wound at electrode site, pregnancy, active deep vein thrombosis

Study details
    Multiple Sclerosis
    Mobility Limitation
    Balance; Distorted
    Gait

NCT07174973

University Health Network, Toronto

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.